New Delhi: An expert panel of the Central Drugs Standards Control Organization (CDSCO) has asked Doctor Reddy’s Laboratories to review the protocols for the second and third phase of testing of the Covid-19 Russian vaccine Sputnik-5 on humans, in this regard. Apply from scratch Sources said on Monday that the Hyderabad-based pharmaceutical company had applied to the Drug Controller General of India last week to get permission for the third phase of testing the Russian vaccine on humans.
Sources told that after considering the application (SEC) on Covid-19 at CDSCO, the company asked the company to review the protocol and submit a fresh application to state that it would be second and third. Wants to test phase together. Further information has also been sought from the company.
“This means that Dr. Reddy’s Laboratories will have to submit a new application,” the source said. According to the SEC, he will have to do both the second and third phase clinical trials, he cannot directly test the vaccine in India in the third phase. ” Doctor Reddy’s Laboratories has entered into an agreement with the Russian Diorite Investment Fund for clinical trials and supplies of Covid-19’s vaccine Sputnik-5.
